Seer (SEER) Capital Expenditures (2020 - 2026)
Seer (SEER) recorded quarterly Capital Expenditures of $9000.0 in Q1 2026, down 80.43% quarter-over-quarter from $46000.0 in Q4 2025, and down 89.41% on a YoY basis from $85000.0 in Q1 2025.
Seer (SEER) Capital Expenditures (2020 - 2026) Analysis & Trends
Seer's Capital Expenditures history runs 7 years deep, the most recent figure standing at $9000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 89.41% year-over-year to $9000.0; the TTM figure through Mar 2026 stood at $55000.0 (up 141.35% YoY), while the FY2025 annual figure was $131000.0, down 47.18% from the prior year.
- Capital Expenditures was $9000.0 for Q1 2026 at Seer, down from $46000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $4.2 million in Q3 2023 to a low of -$4.9 million in Q4 2022.
- Historically, Capital Expenditures has averaged $473588.2 across 5 years, with a median of $466000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures plunged 470.16% in 2022, then jumped 137.24% in 2023.
- A 5-year view of Capital Expenditures shows it stood at -$4.9 million in 2022, then surged by 137.24% to $1.8 million in 2023, then tumbled by 310.55% to -$3.9 million in 2024, then jumped by 101.19% to $46000.0 in 2025, then plunged by 80.43% to $9000.0 in 2026.
- The last three Capital Expenditures figures came in at $9000.0 (Q1 2026), $46000.0 (Q4 2025), and -$31000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -63,220.27 |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | 9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | -3.87 Mn |
| Dec 31, 2024 | -3.87 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 466,000.00 |
| Mar 31, 2024 | 466,000.00 |
| Dec 31, 2023 | 1.84 Mn |
| Dec 31, 2023 | 1.84 Mn |